New Immunotherapy Hope for Most Common Colon Cancer

Scientists discovered that timing might unlock immunotherapy for the 85% of colon cancer patients whose tumors don't respond to current immune treatments.

Early results show 26% of these previously resistant tumors responded when treated before surgery instead of after.